CRL-40,941
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
2-{[Bis(4-fluorophenyl)methyl]sulfinyl}-N-hydroxyacetamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
90212-80-9 |
| ATC code | none |
| PubChem | CID 13316557 |
| ChemSpider |
29785194 |
| Synonyms | Fluorafinil, Fladrafinil |
| Chemical data | |
| Formula | C15H13F2NO3S |
| Molar mass | 325.33 g/mol |
| |
| |
| | |
CRL-40,941 is a wakefulness-promoting agent closely related to adrafinil and modafinil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil. CRL-40,941 was found to produce antiaggressive effects in animals, which adrafinil does not produce.[1]
See also
References
- ↑ US patent 4489095, Lafon, L., "Halogenobenzhydrylsulfinylacetohydroxamic Acids", issued 1984-12-18, assigned to Laboratoire L. Lafon
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
